EVALUATION OF PATHOPHYSIOLOGY BIOMARKERS IN KIDNEY BIOPSIES COLLECTED IN IMAgINATION, A PHASE 3 STUDY OF SEFAXERSEN IN PATIENTS WITH IgA NEPHROPATHY

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 

 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

  Back
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/830af52858976587fa7b8b1b0dd051fb.pdf
EVALUATION OF PATHOPHYSIOLOGY BIOMARKERS IN KIDNEY BIOPSIES COLLECTED IN IMAgINATION, A PHASE 3 STUDY OF SEFAXERSEN IN PATIENTS WITH IgA NEPHROPATHY

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Jonathan
Barratt
Jonathan Barratt jonathan@jonathan-barratt-consulting.co.uk University of Leicester Department of Cardiovascular Sciences Leicester United Kingdom *
Loreto Gesualdo loreto.gesualdo@uniba.it University of Bari Aldo Moro Nephrology, Dialysis and Transplantation Unit, Department of Emergency and Organ Transplantation Bari Italy -
Dana Rizk drizk@uabmc.edu University of Alabama at Birmingham Division of Nephrology, Department of Internal Medicine Birmingham United States -
Hua Li h_li@zju.edu.cn Zhejiang University School of Medicine Department of Nephrology, Sir Run Run Shaw Hospital Hangzhou China -
Irene Noronha irenenor@usp.br University of Sao Paulo Division of Nephrology Sao Paolo Brazil -
Vishal Duggal duggalv1@gene.com Genentech, Inc. South San Francisco United States -
Nadine Schmit nadine.schmit@roche.com F. Hoffmann-LaRoche Ltd Basel Switzerland -
Nikhil Kamath nikhil.kamath@roche.com Roche Products Ltd Welwyn Garden City United Kingdom -
Amanda Nash amanda.nash@roche.com Roche Products Ltd Welwyn Garden City United Kingdom -
Naron Sasenarine naron.narine@roche.com Hoffmann-La Roche Ltd Mississauga, ON Canada -
Chang Liu chang.liu.cl2@roche.com Roche (China) Holding Ltd Shanghai China -
Jeannette Lo lo.jeannette@gene.com Genentech, Inc. South San Francisco United States -
-
-
-